When it comes to medical cannabis, especially the kind used to treat epilepsy, CBD really steals the show. CBD is such a popular cannabinoid in the medical arena that “cannabis oil” and “CBD oil” are used interchangeably by some people and even some publications.

But THC has a lot to offer medically too. It may kill brain cancer cells, for one. And THC may even prove useful in some of the niches that CBD has carved out for itself. Some bold researchers have actually administered a THC/CBD hybrid oil in a clinical trial to children suffering from a severe form of epilepsy.

In a study published Wednesday in the Annals of Clinical and Translational Neurology, researchers at SickKids Hospital in Canada found startling results in treating the potentially debilitating Dravet syndrome with a 2:1 THC to CBD extract.

“We found that 63 per cent of kids had at least a 50 per cent reduction in their seizures,” Dr. Blathnaid McCoy, a staff neurologist at SickKids, told the CBC.

“We also found an overall improvement in quality of life.”

One example of the trial’s success is the case of 16-year-old Abigail Weightman. Before she began cannabis treatment, Abigail was suffering between eight and ten seizures a month. She had become unresponsive, with her family saying that sometimes she would just watch TV with a blank expression, and them unable to tell if she was really taking it in.

Since Abigail began taking the THC/CBD oil, she has only experienced three seizures in 2018 and none at all in the last two months.

Her mother says that the treatment “has made here energetic, busy and active.” “She’s a part of the world now,” she said.

Hopes for THC treatment of Dravet should be tempered. The study was relatively small, with only 20 participants, but Dr. McCoy points out that “very few drugs have data that involves children… This is certainly enough to warrant more research.”

Photo via Flickr user WeedPornDaily